5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.68▼ | 2.68▼ | 2.68▼ | 2.63▼ | 2.59▲ |
MA10 | 2.71▼ | 2.71▼ | 2.70▼ | 2.47▲ | 3.00▼ |
MA20 | 2.61▲ | 2.53▲ | 2.50▲ | 2.57▲ | 5.32▼ |
MA50 | 2.43▲ | 2.39▲ | 2.40▲ | 3.14▼ | 15.45▼ |
MA100 | 2.38▲ | 2.46▲ | 2.58▲ | 5.77▼ | 89.83▼ |
MA200 | 2.49▲ | 2.79▼ | 3.04▼ | 10.68▼ | 3,137.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.008▼ | 0.003▲ | 0.012▲ | 0.103▲ | 1.531▲ |
RSI | 52.981▲ | 54.032▲ | 54.625▲ | 44.753▼ | 24.861▼ |
STOCH | 34.653 | 49.976 | 57.502 | 53.197 | 8.168▼ |
WILL %R | -51.111 | -51.111 | -37.705 | -43.678 | -90.059▼ |
CCI | -63.372 | -31.227 | 4.485 | 73.649 | -74.791 |
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
Tuesday, April 23, 2024 09:00 AM
ToughBuilt Industries Inc. successfully obtained a letter of credit from King Trade Capital (“KTC”), a provider of more than $2.5 billion in capital to over 400 public and private companies ...
|
Tuesday, April 23, 2024 09:00 AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/04/24 | 2.61 | 2.61 | 2.61 | 2.61 | 17,654 |
24/04/24 | 2.73 | 2.80 | 2.5727 | 2.775 | 47,730 |
23/04/24 | 2.69 | 2.99 | 2.602 | 2.80 | 163,452 |
22/04/24 | 2.31 | 2.76 | 2.2082 | 2.75 | 525,593 |
19/04/24 | 2.30 | 2.328 | 2.131 | 2.24 | 54,500 |
18/04/24 | 2.35 | 2.35 | 2.13 | 2.30 | 102,700 |
17/04/24 | 2.2501 | 2.97 | 2.21 | 2.40 | 730,251 |
16/04/24 | 2.25 | 2.305 | 2.12 | 2.16 | 38,061 |
15/04/24 | 2.48 | 2.48 | 2.16 | 2.23 | 53,851 |
12/04/24 | 2.5317 | 2.59 | 2.38 | 2.45 | 27,326 |
|
|
||||
|
|
||||
|
|